Welcome to the Arachnoiditis Bulletins

Bulletin 1 – Explanations and Definitions You Must Know – Revised 3/18

Bulletin 2 – Arachnoiditis No Longer A Rare Disease – Revised 3/18

Bulletin 3 – A Brief History of Arachnoiditis – Revised 10/18

Bulletin 4 – Causes of Arachnoiditis – Revised 10/18

Bulletin 5 – Neuroinflammation is the Root Cause – Revised 10/18

Bulletin 6 – Major Symptoms and Harms of AA – Revised 11/18

Bulletin 7 – Natural Course and Outcome of AA – Revised 11/18

Bulletin 8 – The Diagnosis of AA – Revised 11/18

Bulletin 9 – My Treatment Isn’t Working – Revised 9/18

Bulletin 10 – 10 Component Treatment Protocol – Revised 9/18

Bulletin 11 – Arachnoiditis No Longer Rare

Bulletin 12 – Emergency Treatment for Arachnoiditis

Bulletin 13 – Screening for AA

Bulletin 14 – Ketorolac for AA

Bulletin 15 – Getting Started To Treat and Survive AA

Bulletin 16 – Emergency Treatment for Early or Suspected Arachnoiditis – Revised 2/18

Bulletin 17 – Best Treatment for AA – Revised 3/18

Bulletin 18 – Therapeutic Trials – What are they and why are they essential? – Revised 9/18

Bulletin 19 – Confusion Over Diagnosis of Arachnoiditis – Revised 7/18

Bulletin 20 – Neuroinflammation & Neurodegeneration – Revised 7/18

Bulletin 21 – Self-Help Protocol for Arachnoiditis and Ehlers-Danlos Syndrome

Bulletin 22 – Stem Cells and Electric Stimulators

Bulletin 23 – Most Common Cause of Centralized Intractable Pain (CIP)

Bulletin 24 – Anabolism and Catabolism – You Must Know the Difference

Bulletin 25 – Arachnoiditis Patients Must Have a Compounding Pharmacy